Jeffrey V. Lazarus (Ph.D., MIH, MA) holds positions as an associate research professor at the Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, where he leads the health systems research team, and as Associate Professor at the Faculty of Medicine, University of Barcelona, Spain. His decade-long career as a health systems, HIV and viral hepatitis expert at WHO Europe was followed by three years (2009-2012) as a senior specialist at the Global Fund to Fight AIDS, Tuberculosis, and Malaria, and from 2015 until June 2018 as board chair of the foundation AFEW International.
Prof Lazarus is Vice-Chairman of the board of the EASL International Liver Foundation, a member of the INHSU international education committee and co-chair of the HIV Outcomes Beyond Viral Suppression coalition. He is the author of more than 250 publications and his current scientific work includes leading the Hep C Free Baleares, HBV COMSAVA, and Copenhagen T'n'T projects, the HIV Fourth 90 consensus statement, and the Global NASH Policy study. He is a core member of The Lancet GastroHep Commission on Viral Hepatitis, a commissioner for the EASL-Lancet European Liver Commission and a member of The Lancet COVID-19 Commission public health taskforce.
The Economist Intelligence Unit Hepatitis C Changemaker award (2017)